Skip to Main content Skip to Navigation
Journal articles

Drug resistance mutations in HIV: new bioinformatics approaches and challenges

Abstract : Drug resistance mutations appear in HIV under treatment pressure. Resistant variants can be transmitted to treatmentnaive individuals, which can lead to rapid virological failure and can limit treatment options. Consequently, quantifying the prevalence, emergence and transmission of drug resistance is critical to effectively treating patients and to shape health policies. We review recent bioinformatics developments and in particular describe: (1) the machine learning approaches intended to predict and explain the level of resistance of HIV variants from their sequence data; (2) the phylogenetic methods used to survey the emergence and dynamics of resistant HIV transmission clusters; (3) the impact of deep sequencing in studying within-host and between-host genetic diversity of HIV variants, notably regarding minority resistant variants.
Document type :
Journal articles
Complete list of metadata
Contributor : Hal Sorbonne Université Gestionnaire Connect in order to contact the contributor
Submitted on : Thursday, October 7, 2021 - 4:34:22 PM
Last modification on : Thursday, January 6, 2022 - 4:22:02 PM
Long-term archiving on: : Saturday, January 8, 2022 - 7:33:17 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License



Luc Blassel, Anna Zhukova, Christian Villabona-Arenas, Katherine Atkins, Stéphane Hué, et al.. Drug resistance mutations in HIV: new bioinformatics approaches and challenges. Current Opinion in Virology, Elsevier, 2021, 51, pp.56 - 64. ⟨10.1016/j.coviro.2021.09.009⟩. ⟨hal-03369954⟩



Les métriques sont temporairement indisponibles